These findings demonstrate the prognostic importance of immunosuppressive macrophages in locally advanced prostate tumors, with intriguing findings that the level of infiltration of CD163+ macrophages in tumor‐adjacent normal‐like epithelium is the strongest independent predictor of adverse clinical outcomes. This evidence concerns the gene CD163 and neoplasm.